Terms: = Breast cancer AND NF2, ACN, 4771, ENSG00000186575, P35240, SCH, Merlin, BANF AND Prognosis
10 results:
1. Patients achieved pCR during neoadjuvant chemotherapy had better outcome than adjuvant chemotherapy setting in breast cancer: A comparative study.
Chen J; Jin L; Chen L; Bian Z; Li Z; Cao S; Zhou J; Xu L; Zhao W; Wang Q
Cancer Treat Res Commun; 2023; 36():100719. PubMed ID: 37187018
[TBL] [Abstract] [Full Text] [Related]
2. RICH1 inhibits breast cancer stem cell traits through activating kinases cascade of Hippo signaling by competing with merlin for binding to Amot-p80.
Tian Q; Gao H; Zhou Y; Zhu L; Yang J; Wang B; Liu P; Yang J
Cell Death Dis; 2022 Jan; 13(1):71. PubMed ID: 35064101
[TBL] [Abstract] [Full Text] [Related]
3. Antitumor potential of dark sweet cherry sweet (Prunus avium) phenolics in suppressing xenograft tumor growth of MDA-MB-453 breast cancer cells.
Noratto G; Layosa MA; Lage NN; Atienza L; Ivanov I; Mertens-Talcott SU; Chew BP
J Nutr Biochem; 2020 Oct; 84():108437. PubMed ID: 32615370
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathologic and genetic characteristics of young patients with pleural diffuse malignant mesothelioma.
Vivero M; Bueno R; Chirieac LR
Mod Pathol; 2018 Jan; 31(1):122-131. PubMed ID: 28884745
[TBL] [Abstract] [Full Text] [Related]
5. Role of merlin/nf2 inactivation in tumor biology.
Petrilli AM; Fernández-Valle C
Oncogene; 2016 Feb; 35(5):537-48. PubMed ID: 25893302
[TBL] [Abstract] [Full Text] [Related]
6. The cyclin D1-CDK4 oncogenic interactome enables identification of potential novel oncogenes and clinical prognosis.
Jirawatnotai S; Sharma S; Michowski W; Suktitipat B; Geng Y; Quackenbush J; Elias JE; Gygi SP; Wang YE; Sicinski P
Cell Cycle; 2014; 13(18):2889-900. PubMed ID: 25486477
[TBL] [Abstract] [Full Text] [Related]
7. Function and cancer genomics of FAT family genes (review).
Katoh M
Int J Oncol; 2012 Dec; 41(6):1913-8. PubMed ID: 23076869
[TBL] [Abstract] [Full Text] [Related]
8. KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals.
Moleirinho S; Chang N; Sims AH; Tilston-Lünel AM; Angus L; Steele A; Boswell V; Barnett SC; Ormandy C; Faratian D; Gunn-Moore FJ; Reynolds PA
Oncogene; 2013 Apr; 32(14):1821-30. PubMed ID: 22614006
[TBL] [Abstract] [Full Text] [Related]
9. Clinical implications of the influence of Ehm2 on the aggressiveness of breast cancer cells through regulation of matrix metalloproteinase-9 expression.
Yu H; Ye L; Mansel RE; Zhang Y; Jiang WG
Mol Cancer Res; 2010 Nov; 8(11):1501-12. PubMed ID: 21047774
[TBL] [Abstract] [Full Text] [Related]
10. Impact of axillary dissection on staging and regional control in breast tumors < or = 10 mm--the DBCG experience. The Danish breast cancer Cooperative Group (DBCG), Rigshisoutalet, Copenhagen, Denmark.
Axelsson CK; Rank F; Blichert-Toft M; Mouridsen HT; Jensen MB
Acta Oncol; 2000; 39(3):283-9. PubMed ID: 10987222
[TBL] [Abstract] [Full Text] [Related]
